These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3667796)

  • 1. Qualitative and quantitative analysis of a new sulphur-containing nitrosourea in blood by high-performance liquid chromatography.
    Labarre P; Godeneche D; Madelmont JC; Triana K; Mathe G; Veyre A
    J Chromatogr; 1987 Aug; 419():381-7. PubMed ID: 3667796
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of tauromustine, a nitrosourea-based antitumour agent, in plasma by high-performance liquid chromatography.
    Polacek J; Gunnarsson PO; Brandin S
    J Chromatogr; 1988 Mar; 425(2):424-8. PubMed ID: 3372655
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of tauromustine and its demethylated metabolites in plasma and urine.
    Polacek J; Gustafsson B; Brandin S; Ottersgård-Brorsson A
    J Chromatogr; 1990 Mar; 526(1):151-7. PubMed ID: 2341526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of 1-2(chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea in blood and urine of man.
    Nakajima O; Yoshida Y; Kubota T; Takemasa Y; Koyama Y
    J Chromatogr; 1982 May; 229(2):481-6. PubMed ID: 6212589
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis for nitrosourea antitumor agents by gas chromatography--mass spectrometry.
    Smith RG; Blackstock SC; Cheung LK; Loo TL
    Anal Chem; 1981 Jul; 53(8):1205-8. PubMed ID: 7270897
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic studies on 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). III. Pharmacokinetics of a new nitrosourea antitumor agent TA-077 in humans (a phase I study).
    Hayashida K; Miura Y; Arai Y; Takeyama S; Wakui A; Yokoyama M; Kanamaru R; Majima H; Taguchi T; Ohmichi M
    J Pharmacobiodyn; 1987 Oct; 10(10):523-7. PubMed ID: 3440914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry.
    Smith RG; Cheung LK; Feun LG; Loo TL
    Biomed Mass Spectrom; 1983 Jul; 10(7):404-7. PubMed ID: 6616018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of TCNU (tauromustine) in human malignant glioma: pharmacokinetic studies and clinical implications.
    Whittle IR; MacPherson JS; Miller JD; Smyth JF
    J Neurosurg; 1990 May; 72(5):721-5. PubMed ID: 2157825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse model.
    Loadman PM; Bibby MC; Double JA; McElhinney RS
    Invest New Drugs; 1992 Aug; 10(3):149-58. PubMed ID: 1428724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability of two nitrosoureas, carmustine and fotemustine in rat cortex.
    Meulemans A; Giroux B; Hannoun P; Henzel D; Bizzari JP; Mohler J
    Chemotherapy; 1989; 35(5):313-9. PubMed ID: 2791708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of NK611, a novel water-soluble derivative of etoposide, and its metabolite (DeNK611) in dog plasma by column-switching high performance liquid chromatography.
    Machida M; Tanaka S; Nakamori K
    Biomed Chromatogr; 1993; 7(2):82-5. PubMed ID: 8485379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic studies on 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). II. Hydrolysis by tissue homogenates and drug uptake by tumor cells in vitro.
    Hayashida K; Oda K; Akaike Y; Arai Y; Takeyama S
    J Pharmacobiodyn; 1987 Oct; 10(10):515-22. PubMed ID: 3326928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies on 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). I. Blood and tissue concentrations of a new nitrosourea antitumor agent TA-077 and its metabolite TA-G after intravenous injection of TA-077 in various experimental animals.
    Hayashida K; Akaike Y; Nakamura S; Miura Y; Arai Y; Ono Y; Takeyama S
    J Pharmacobiodyn; 1987 Oct; 10(10):507-14. PubMed ID: 3440913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of derivatization reactions with adsorptive stripping voltammetry for determining fotemustine in biological samples.
    Díaz De Guereñu MM; Barrio RJ; Arranz A; Arranz JF
    J Pharm Biomed Anal; 1992 Jul; 10(7):481-6. PubMed ID: 1420472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatographic analysis of N,N',N"-triethylenethiophosphoramide in human plasma.
    Tinsley PW; O'Dwyer PJ; LaCreta FP
    J Chromatogr; 1989 Oct; 495():318-23. PubMed ID: 2515200
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
    Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
    Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone in plasma by solid-phase extraction and high-performance liquid chromatography.
    Betteridge RF; Bosanquet AG; Hunt P; Gilby ED
    J Chromatogr; 1988 Nov; 432():352-7. PubMed ID: 3220904
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA-nitrosourea interactions. High-performance liquid chromatography of cross-linked dinucleosides and substituted deoxynucleosides.
    Maggio AF; Pompon A; Lucas M; Barascut JL; Imbach JL
    J Chromatogr; 1988 Jan; 436(1):23-30. PubMed ID: 3372660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interspecies comparison of pharmacokinetic parameters of fotemustine (nitrosourea S 10036): mice, rats, monkeys, dogs and man].
    Lucas C; Ings B; Gray AJ; Deloffre P; Lokiec F; Campbell B; Beerblock K
    Bull Cancer; 1989; 76(8):863-5. PubMed ID: 2515897
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
    Godeneche D; Madelmont JC; Moreau MF; Duprat J; Chabard JL; Plagne R; Meyniel G
    Drug Metab Dispos; 1985; 13(2):220-6. PubMed ID: 2859172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.